Open Access

Classical galactosemia in a Thai infant: case report and review of the literature


Cite

Figure 1

A. Hematoxylin and eosin staining (×200). B. Masson trichrome staining (×200). Severe hepatocellular damage with giant cell transformation, intralobular, and portal fibrosis
A. Hematoxylin and eosin staining (×200). B. Masson trichrome staining (×200). Severe hepatocellular damage with giant cell transformation, intralobular, and portal fibrosis

Figure 2

Gas chromatography-mass spectrometry demonstrates an increase excretion of galactose, galactitol, and galactonate in the patient’s urine.
Gas chromatography-mass spectrometry demonstrates an increase excretion of galactose, galactitol, and galactonate in the patient’s urine.

Figure 3

A. Hematoxylin and eosin staining (×100) and B. Masson trichrome staining (×100). Follow-up liver biopsy, after galactose restriction revealed no active liver damage, but residual fibrosis was demonstrated by Masson trichrome staining.
A. Hematoxylin and eosin staining (×100) and B. Masson trichrome staining (×100). Follow-up liver biopsy, after galactose restriction revealed no active liver damage, but residual fibrosis was demonstrated by Masson trichrome staining.

Figure 4

The Leloir pathway and alternative pathways for galactose metabolism: dotted lines a = aldose reductase and b = pentose phosphate pathway. 1 = hexokinase, 2 = phosphoglucomutase, 3 = UDP-glucose pyrophosphorylase. GALK = galactokinase, GALT = galactose-1-phosphate uridyl transferase, GALE = galactose-6-phosphate epimerase.
The Leloir pathway and alternative pathways for galactose metabolism: dotted lines a = aldose reductase and b = pentose phosphate pathway. 1 = hexokinase, 2 = phosphoglucomutase, 3 = UDP-glucose pyrophosphorylase. GALK = galactokinase, GALT = galactose-1-phosphate uridyl transferase, GALE = galactose-6-phosphate epimerase.

The clinical features and laboratory results of Thai galactosemia cases in English literature

Sethond case [11]Third case [12]Present case
Age2 months11 days4 months
SexFemaleMaleMale
Family HistoryNonconsanguinityNonconsanguinityNonconsanguinity
Clinical features
Poor feedingYesYesYes
VomitingNoYesYes
HepatomegalyYesYesYes
Gram negative sepsisNoNoYes
Lethargy and hypotoniaNoYesYes
CataractYesNoNo
Laboratory
Cholestasis jaundiceYesYesYes
Urine GC/MSRising galactose, galactitol, and galactonateRising galactose, galactitol, and galactonateRising galactose, galactitol, and galactonate
Genetic analysisNoMutation of p.R259W in exon 8 and p. E340K in exon 10No
Liver biopsy findingNoNoSevere hepatocyte loss with giant cell transformation and cholestasis
Long-term complicationsUnavailableUnavailableDelayed development and defects on speech
eISSN:
1875-855X
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, other, Clinical Medicine